Oncol­o­gy 2022

PORT for Health – con­fer­ence series

“PORT for Health” is an annu­al con­fer­ence series focused on life sci­ences that brings togeth­er sci­en­tists, med­ical prac­ti­tion­ers and indus­try pro­fes­sion­als. Each year the con­fer­ence dis­cuss­es a spe­cif­ic sci­en­tif­ic top­ic that is impor­tant with­in the broad land­scape of mod­ern bio­med­ical sci­ence and has strong impli­ca­tions for human health with an alter­nat­ing bien­ni­al sched­ule focus­ing either on neu­ro­science or oncol­o­gy. Themes dis­cussed at the meet­ing include the fun­da­men­tal mol­e­c­u­lar mech­a­nisms, devel­op­ment of phys­i­o­log­i­cal mod­els of human dis­ease, find­ing of new drug tar­gets and oppor­tu­ni­ties for nov­el tar­get­ed treat­ments in per­son­alised med­i­cine. Read more on the edi­tions site.

PORT for Health: Neuroscience 2023 conference at Łukasiewicz – PORT
PORT FOR HEALTH Neurosciece is organized by the Life Sciences and Biotechnology Center (LSnBC) located at the Łukasiewicz – PORT

PORT for Health: Oncol­o­gy 2022 conference

PORT FOR HEALTH is orga­nized by the Life Sci­ences and Biotech­nol­o­gy Cen­ter (LSnBC) locat­ed at the Łukasiewicz – PORT Pol­ish Cen­ter for Tech­nol­o­gy Devel­op­ment, a part of the Łukasiewicz Research Net­work. The mis­sion of the dynam­i­cal­ly grow­ing LSnBC is to tack­le the biggest chal­lenges of mod­ern med­i­cine through top-notch, trans­la­tion­al research accom­plished by teams led by cre­ative and expe­ri­enced leaders.

Neu­ro­science is one of the research pil­lars of LSnBC. We host sev­er­al groups inves­ti­gat­ing mol­e­c­u­lar mech­a­nisms of dis­eases of the cen­tral ner­vous sys­tem: depres­sion, schiz­o­phre­nia, eat­ing dis­or­ders, neu­ro­mus­cu­lar dis­or­ders, and neu­rode­gen­er­a­tion. Our PIs use cut­ting edge tech­niques of genet­ic manip­u­la­tion, imag­ing, behav­ioral and cel­lu­lar assays to under­stand how the impair­ment of select­ed path­ways con­tributes to a dys­func­tion of spe­cif­ic cell in rel­e­vant brain cir­cuits. Our results will help to for­mu­late and val­i­date nov­el ther­a­peu­tic con­cepts for treat­ing brain disorders.